CClinicalTrials.gg
CompletedNCT01200316Updated Nov 30, 2017

Rocking Motion: Physiologic Effect on the Surgical Stress Response

A Phase 1 interventional study of Standard of Care and Rocking Chair Motion in Gastrointestinal Cancer, sponsored by M.D. Anderson Cancer Center. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-11-30.

Sponsored by M.D. Anderson Cancer Center · Phase 1, Interventional, and Treatment

Phase
Phase 1
Study type
Interventional
Enrollment
86
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

After having abdominal surgery, patients often experience a lack of bowel function that can cause nausea, vomiting, abdominal swelling, pain, and/or discomfort. This is known as "post-operative ileus." Patients are usually not allowed to leave the hospital until their doctor is sure that their bowel function has returned.

The goal of this clinical research study is to compare using a rocking chair to the standard of care in improving post-operative ileus after abdominal surgery.

Read the detailed description

The standard method used to help the return of bowel function after surgery is to have patient get out of bed, sit in a chair for a period of time, and then begin walking the first day after surgery. Patients are then asked to increase the time they spend sitting in the chair and walking every day. However, it is not clear that this is the best method to assist in the return of normal bowel function. Some studies have shown that rocking in a rocking chair may help normal bowel function to return more quickly.

Study Groups:

If you agree to take part in this study, you will be randomly assigned (as in the flip of a coin) to 1 of 2 study groups. You will have an equal chance of being assigned to either group:

  • If you are in Group A, you will use the "rocking chair method." Beginning the first day after surgery, you will sit in a rocking chair and rock back and forth for 10-20 minutes at a time. This will be done for at least 60 minutes (1 hour) per day, until you pass gas for the first time after surgery. The study staff will show the correct method to rock in the rocking chair and give you time to practice while you are in the clinic.
  • If you are in Group B, you will use the standard method only. Beginning the first day after surgery, you will sit in a non-rocking chair for at least 60 minutes each day until you pass gas for the first time after surgery.

No matter what group you are in, you will also be asked to begin walking the first day after surgery until you pass gas for the first time after surgery.

You will wear an activity recorder all day attached to a wrist band in order to record your time spent in bed, in the rocking or non-rocking chair, and an activity monitor around your waist to record the time and distance walked during each 24-hour period. The study staff will show you how to wear this activity recorder. You will be encouraged by the study staff to increase the time spent in the chair and walking each day.

You will be given a pencil and pad of paper to note the date and time you first pass gas after surgery.

Study Tests:

On the day before you have surgery, the following tests and procedures will be performed:

  • You will be asked to provide demographic information (such as your age and marital status). This information will be coded to protect your privacy.
  • You will complete a questionnaire about any symptoms you may be experiencing. This should take about 10 minutes to complete.
  • Saliva will be collected to measure your cortisol level. For this saliva to be collected, you will spit into a tube. The level of cortisol in your saliva is used to measure your response to stress.

Every morning while you are in the hospital and until you pass gas for the first time after surgery:

  • You will be asked if you have passed gas.
  • Saliva will be collected to measure your cortisol level.
  • You will complete the symptom questionnaire.
  • It will take about ten minutes to complete the questionnaire and to collect the saliva sample.
  • You will perform the exercises described in the "Study Groups" section, depending on which group you are assigned to.

Length of Study:

You will be on study from the first day after surgery until you pass gas (usually about 3-5 days). You will be taken off study if you cannot tolerate rocking in a rocking chair, sitting in a non-rocking chair, or walking, due to discomfort or any other reason.

This is an investigational study. There are no additional costs to you for taking part in this study.

Up to 80 patients will take part in the study. All will be enrolled at MD Anderson.

02

Conditions studied

  • Gastrointestinal Cancer

Keywords

  • Colon Cancer
  • Abdominal Surgery
  • Stress
  • Rocking Motion
  • Salivary Cortisol
  • Postoperative Ileus
03

In context

Gastrointestinal Neoplasms

778 studies on the registry are indexed under Gastrointestinal Neoplasms; 230 are open to participants now.

This study's enrollment of 86 is above the median of 61 across 568 interventional studies indexed under Gastrointestinal Neoplasms.

Browse Gastrointestinal Neoplasms studies →

Lead sponsor

M.D. Anderson Cancer Center is the lead sponsor of 2,999 studies on the registry; 581 are open to participants now.

Of its 599 completed or terminated interventional studies of FDA-regulated products, 402 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. At least 18 years old
  2. Speak and read English
  3. Scheduled to undergo abdominal surgery
  4. Tolerate sitting in a rocking or nonrocking chair
  5. Able to ambulate
  6. Scheduled to receive epidural or intravenous patient controlled analgesia
  7. Cognitively intact
  8. Signed a study-specific informed consent prior to study entry
  9. May include patients undergoing ileostomy or colostomy reversal

Exclusion criteria

Exclusion Criteria:

  1. All others will be excluded.
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
Single (Participant)
Enrollment
86 participants (actual)

Study arms

  • Experimental
    Standard of Care Group

    Post surgical patient to sit in a non-rocking chair for at least sixty minutes per day, and ambulating at least three times per day.

    Procedure: Standard of Care · Behavioral: Questionnaire

  • Experimental
    Rocking Motion Group

    Post surgical patient to rock in a rocking chair in 10-20 minute increments for at least sixty minutes per day, and ambulating at least three times per day.

    Procedure: Rocking Chair Motion · Behavioral: Questionnaire

Interventions

  • ProcedureStandard of Care

    Post surgical patient to sit in a non-rocking chair for at least sixty minutes per day, and ambulating at least three times per day.

  • ProcedureRocking Chair Motion

    Post surgical patient to rock in a rocking chair in 10-20 minute increments for at least sixty minutes per day, and ambulating at least three times per day.

  • BehavioralQuestionnaire

    Beginning on day of surgery till discharge (3-5 days)

    Also known as: Survey

06

What researchers measure

Primary outcomes

  1. Efficacy of Rocking Chair Motion on Surgical-Induced Stress

    Efficacy of rocking chair motion on surgical-induced stress response as measured by salivary cortisol sample collected each morning in two groups of colon cancer patients recovering from abdominal surgery randomized to receive either a rocking chair motion intervention or standard care.

    Time frame: 3 - 5 days

07

Study locations

1 site
  • University of Texas MD Anderson Cancer Center
    Houston, Texas 77030, United States
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 30, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01200316
Lead sponsor
M.D. Anderson Cancer Center
Collaborators
National Institutes of Health (NIH)
Responsible party
Sponsor
First posted
Sep 13, 2010
Start date
Feb 1, 2012
Primary completion
Nov 20, 2017
Completion
Nov 20, 2017
Last update
Nov 30, 2017

Study contacts

Xin S. Wang, MD, MPH
principal investigator · M.D. Anderson Cancer Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion